ENPLACE
Device
FEMSelect Inc.
Total Payments
$123,509
Transactions
374
Doctors
230
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $64,818 | 183 | 131 |
| 2023 | $32,660 | 150 | 100 |
| 2022 | $26,031 | 41 | 27 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $93,203 | 39 | 75.5% |
| Food and Beverage | $28,207 | 330 | 22.8% |
| Unspecified | $2,100 | 5 | 1.7% |
Payments by Type
General
$121,409
369 transactions
Research
$2,100
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| The NeuGuide System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Post-Market Surveillance Clinical Study | FEMSelect Inc. | $2,100 | 1 |
Top Doctors Receiving Payments for ENPLACE — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Obstetrics & Gynecology | West Palm Beach, FL | $191.27 | 3 |
| , M.D | Student in an Organized Health Care Education/Training Program | Nacogdoches, TX | $176.71 | 2 |
| , M.D | Obstetrics & Gynecology | Arden, NC | $174.28 | 1 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Flower Mound, TX | $163.30 | 1 |
| , MD | Obstetrics & Gynecology | Bossier City, LA | $161.39 | 1 |
| , M.D | Obstetrics & Gynecology | Henderson, NV | $156.67 | 1 |
| , MD | Obstetrics & Gynecology | San Jose, CA | $146.02 | 2 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Houston, TX | $145.03 | 1 |
| , MD | Obstetrics & Gynecology | Houston, TX | $140.72 | 2 |
| , MEDICAL DOCTOR | Urology | Newport Beach, CA | $138.68 | 1 |
| , MD | Urology | Roslyn Heights, NY | $138.68 | 1 |
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Cleveland, OH | $138.68 | 1 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Arlington, TX | $138.68 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | New York, NY | $138.68 | 1 |
| , MD | Obstetrics & Gynecology | Syracuse, NY | $137.55 | 1 |
| , MD, MPH | Orthopaedic Surgery | Austin, TX | $135.00 | 1 |
| , M.D | Gynecology | San Antonio, TX | $131.40 | 1 |
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Los Angeles, CA | $131.02 | 1 |
| , M.D | Obstetrics & Gynecology | Muskegon, MI | $128.70 | 2 |
| , MD | Obstetrics & Gynecology | Saginaw, MI | $127.89 | 1 |
| , MD | Urology | Sugar Land, TX | $124.87 | 1 |
| Hemikaa Devakumar | Urogynecology and Reconstructive Pelvic Surgery | Litchfield Park, AZ | $123.70 | 1 |
| , MD | Gynecology | St Petersburg, FL | $119.98 | 1 |
| , M.D | Gynecology | Ventura, CA | $116.67 | 1 |
| , M.D | Urology | Lakewood, CA | $113.89 | 1 |
Ad
Manufacturing Companies
- FEMSelect Inc. $123,509
Product Information
- Type Device
- Total Payments $123,509
- Total Doctors 230
- Transactions 374
About ENPLACE
ENPLACE is a device associated with $123,509 in payments to 230 healthcare providers, recorded across 374 transactions in the CMS Open Payments database. The primary manufacturer is FEMSelect Inc..
Payment data is available from 2022 to 2024. In 2024, $64,818 was paid across 183 transactions to 131 doctors.
The most common payment nature for ENPLACE is "Consulting Fee" ($93,203, 75.5% of total).
ENPLACE is associated with 1 research study, including "The NeuGuide System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Post-Market Surveillance Clinical Study" ($2,100).